Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease on behalf of the lacunar-B.I.C.H.A.T. investigators

Cerebrovascular Diseases

Volumn 36, Issue 2, 2013, Pages 131-138

  Lavallée, Philippa C ^a,b   Labreuche, Julien ^a   Faille, Dorothée ^a,c   Huisse, Marie Geneviève ^a,c   Nicaise Roland, Pascale ^b   Dehoux, Monique ^b   Gongora Rivera, Fernando ^b   Jaramillo, Arturo ^b   Brenner, David ^b   Deplanque, Dominique ^e   Klein, Isabelle F ^a,c   Touboul, Pierre Jean ^a,b   Vicaut, Eric ^d   Ajzenberg, Nadine ^a,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e UNIV LILLE   (France)

Author keywords

Endothelial dysfunction; Lacunar infarcts; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CLOPIDOGREL; CREATININE; FIBRINOGEN RECEPTOR; HOMOCYSTEINE; PADGEM PROTEIN; VON WILLEBRAND FACTOR; ACTIVATED GLYCOPROTEIN IIB; ACTIVATED GLYCOPROTEIN IIIA; ANTIGEN; BIOLOGICAL MARKER; HIGH SENSITIVITY C REACTIVE PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BRAIN ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; EMBOLISM; ENDOTHELIAL DYSFUNCTION; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PLATELET MICROPARTICLE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SHEAR FLOW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ATHEROSCLEROSIS; DIABETES MELLITUS; ENDOTHELIUM; HYPERTENSION; PROTEIN BLOOD LEVEL; SMALL DEEP INFARCT;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CEREBRAL SMALL VESSEL DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION; RISK FACTORS; STROKE; VON WILLEBRAND FACTOR;

EID: 84885599180     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000353671     Document Type: Article

References (32)

1. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG: New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis 2009; 27: 502-508
2. Fisher CM: The arterial lesions underlying lacunes. Acta Neuropathol 1968; 12: 1-15
3. Wardlaw JM: What causes lacunar stroke J Neurol Neurosurg Psychiatry 2005; 76: 617-619
4. Hassan A, Hunt BJ, O?Sullivan M, Bell R, D?Souza R, Jeffery S, Bamford JM, Markus HS: Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004; 127: 212-219
5. Hassan A, Gormley K, O?Sullivan M, Knight J, Sham P, Vallance P, Bamford J, Markus H: Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 2004; 35: 654-659
6. Lammie GA: Hypertensive cerebral small vessel disease and stroke. Brain Pathol 2002; 12: 358-370
7. Wardlaw JM, Sandercock PA, Dennis MS, Starr J: Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia Stroke 2003; 34: 806-812
8. Constans J, Conri C: Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta 2006; 368: 33-47
9. Hein TW, Singh U, Vasquez-Vivar J, Devaraj S, Kuo L, Jialal I: Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis 2009; 206: 61-68
10. Hassan A, Hunt BJ, O?Sullivan M, Parmar K, Bamford JM, Briley D, Brown MM, Thomas DJ, Markus HS: Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003; 126: 424-432
11. Uchiyama S, Yamazaki M, Maruyama S, Handa M, Ikeda Y, Fukuyama M, Itagaki I: Shearinduced platelet aggregation in cerebral ischemia. Stroke 1994; 25: 1547-1551
12. Konstantopoulos K, Grotta JC, Sills C, Wu KK, Hellums JD: Shear-induced platelet aggregation in normal subjects and stroke patients. Thromb Haemost 1995; 74: 1329-1334
13. Cherian P, Hankey GJ, Eikelboom JW, Thom J, Baker RI, McQuillan A, Staton J, Yi Q: Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes. Stroke 2003; 34: 2132-2137
14. Tsai NW, Chang WN, Shaw CF, Jan CR, Chang HW, Huang CR, Chen SD, Chuang YC, Lee LH, Wang HC, Lee TH, Lu CH: Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke. Thromb Res 2009; 124: 213-218
15. Ajzenberg N, Aubry P, Huisse MG, Cachier A, El Amara W, Feldman LJ, Himbert D, Baruch D, Guillin MC, Steg PG: Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study. J Am Coll Cardiol 2005; 45: 1753-1756
16. Deplanque D, Lavallee PC, Labreuche J, et al, Lacunar-BICHAT Investigators: Cerebral and extracerebral vasoreactivity in symptomatic lacunar stroke patients: a case-control study. Int J Stroke 2013; 8: 413-421
17. Lavallee PC, Labreuche J, Gongora-Rivera F, et al: Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease. Stroke 2009; 40: 1721-1728
18. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F, Mutin M, Sanmarco M, Sampol J, Dignat-George F: In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102
19. Scheltens P, Barkhof F, Leys D, et al: A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993; 114: 7-12
20. Kozuka K, Kohriyama T, Nomura E, Ikeda J, Kajikawa H, Nakamura S: Endothelial markers and adhesion molecules in acute ischemic stroke-sequential change and differences in stroke subtype. Atherosclerosis 2002; 161: 161-168
21. Yamazaki M, Uchiyama S, Iwata M: Measurement of platelet fibrinogen binding and P-selectin expression by flow cytometry in patients with cerebral infarction. Thromb Res 2001; 104: 197-205
22. SPS3 Investigators, Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LA: Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012; 367: 817-825
23. Bath PM, Blann A, Smith N, Butterworth RJ: von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke sub-type and functional outcome. Platelets 1998; 9: 155-159
24. Catto AJ, Carter AM, Barrett JH, Bamford J, Rice PJ, Grant PJ: von Willebrand factor and factor VIII:C in acute cerebrovascular disease. Relationship to stroke subtype and mortality. Thromb Haemost 1997; 77: 1104-1108
25. Ruggeri ZM: Structure and function of von Willebrand factor. Thromb Haemost 1999; 82: 576-584
26. Lenting PJ, Pegon JN, Groot E, de Groot PG: Regulation of von Willebrand factor-platelet interactions. Thromb Haemost 2010; 104: 449-455
27. Lip GY, Blann A: von Willebrand factor: a marker of endothelial dysfunction in vascular disorders Cardiovasc Res 1997; 34: 255-265
28. Elbaz A, Poirier O, Moulin T, Chedru F, Cambien F, Amarenco P, GENIC Investigators: Association between the Glu298Asp polymorphism in the endothelial constitutive nitric oxide synthase gene and brain infarction. Stroke 2000; 31: 1634-1639
29. Wardlaw JM, Doubal F, Armitage P, Chappell F, Carpenter T, Munoz Maniega S, Farrall A, Sudlow C, Dennis M, Dhillon B: Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol 2009; 65: 194-202
30. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA: Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997; 95: 1119-1121
31. Woo KS, Chook P, Lolin YI, Cheung AS, Chan LT, Sun YY, Sanderson JE, Metreweli C, Celermajer DS: Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 1997; 96: 2542-2544
32. Fassbender K, Mielke O, Bertsch T, Nafe B, Froschen S, Hennerici M: Homocysteine in cerebral macroangiography and microangiopathy. Lancet 1999; 353: 1586-1587